GO:0031047 regulatory ncRNA-mediated gene silencing: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031047 (regulatory ncRNA-mediated gene silencing) describes how non-coding RNAs reduce target gene expression pre-transcriptionally via heterochromatin assembly or co-/post-transcriptionally via RNA degradation, splicing interference, or translational blockade.
• The process begins after the inhibitory ncRNA is transcribed and includes RNA processing, nuclear export, RISC loading, and the eventual effect on transcription or translation.
• Key molecular players include Argonaute/PIWI proteins, small RNAs (miRNAs, siRNAs, piRNAs), and long non-coding RNAs such as Kcnq1ot1 and XUTs.
• Dysregulation of ncRNA-mediated silencing is implicated in cancer, chronic pain, endometriosis, and stem cell biology.
• The Gene Ontology has been extended to represent ncRNA-mediated regulation, improving annotation and computational analysis of these pathways.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of ncRNA silencing components in disease contexts.
Description
Regulatory non-coding RNA-mediated gene silencing (GO:0031047) is a fundamental biological process in which non-coding RNA molecules reduce the expression of target genes. This process operates at multiple levels, including pre-transcriptional heterochromatin assembly and co- or post-transcriptional RNA degradation, splicing interference, or translational repression. The Gene Ontology term captures the full lifecycle of the inhibitory RNA, from transcription and processing to nuclear export, RISC loading, and the ultimate effect on gene expression. Understanding this process is critical because it governs diverse cellular functions, including development, stem cell maintenance, and stress responses. Research into GO:0031047 has revealed a wide array of ncRNA classes, such as microRNAs, small interfering RNAs, PIWI-interacting RNAs, and long non-coding RNAs, each with distinct mechanisms and targets. For example, the long non-coding RNA Kcnq1ot1 mediates chromatin-level silencing, while XUTs in yeast represent antisense regulatory ncRNAs sensitive to Xrn1. These examples highlight the evolutionary conservation and functional diversity of ncRNA-mediated silencing. Dysregulation of this process is increasingly linked to human disease. Altered ncRNA networks contribute to cancer progression, chronic pain, and endometriosis. As a result, researchers require robust experimental models to dissect the causal roles of ncRNA silencing components. This article provides a comprehensive overview of GO:0031047, its mechanisms, key genes, disease relevance, and modern research methods, with a focus on CRISPR-based approaches.
regulatory ncRNA-mediated gene silencing At A Glance
| GO ID | GO:0031047 |
|---|---|
| GO term | regulatory ncRNA-mediated gene silencing |
| Ontology | biological_process |
| Synonym | gene silencing by RNA; RNA-dependent gene silencing; RNA-mediated gene silencing |
| Major function | Reduction of target gene expression via non-coding RNA molecules at transcriptional or post-transcriptional levels |
| Process start | After transcription of the inhibitory ncRNA molecule |
| Key steps | ncRNA processing, nuclear export, RISC loading, target recognition, gene silencing |
| Cellular location | Nucleus and cytoplasm (varies by ncRNA class and target) |
| Representative ncRNAs | miRNAs, siRNAs, piRNAs, lncRNAs (e.g., Kcnq1ot1, XUTs) |
What Is GO:0031047?
GO:0031047, regulatory ncRNA-mediated gene silencing, is defined as a process in which a regulatory non-coding RNA molecule reduces the expression of target genes. This reduction can occur pre-transcriptionally through heterochromatin assembly that prevents transcription, or co-/post-transcriptionally by targeting RNAs for degradation, interfering with splicing, or blocking translation. The process starts once the inhibitory RNA has been transcribed and encompasses RNA processing steps such as cleavage, chemical modifications, transport from the nucleus to the cytoplasm, loading onto the RISC complex, and the final effect on transcription or translation.
Why Is regulatory ncRNA-mediated gene silencing Important in Cell Biology?
GO:0031047 is essential because it governs a vast array of gene regulatory networks that control development, differentiation, and homeostasis. Dysregulation of ncRNA-mediated silencing is a hallmark of many human diseases, including cancer, chronic pain, and endometriosis. Moreover, the process is a major source of regulatory complexity in eukaryotic genomes, and its annotation in the Gene Ontology facilitates computational and comparative studies. Understanding its mechanisms can lead to novel therapeutic strategies targeting ncRNAs or their protein partners.
• Controls gene expression at transcriptional and post-transcriptional levels, influencing nearly all cellular processes.
• Plays a critical role in stem cell maintenance and differentiation through Polycomb group protein interactions.
• Dysregulated in multiple cancers, where ncRNAs can act as oncogenes or tumor suppressors.
• Implicated in chronic pain development, offering potential targets for analgesic therapies.
• Involved in endometriosis progression via competing endogenous RNA networks.
• Conserved from yeast to humans, as shown by XUTs in yeast and Kcnq1ot1 in mammals.
• Provides a mechanism for epigenetic inheritance and chromatin-based silencing.
• Serves as a rich source of biomarkers for liquid biopsy applications in cancer.
• Enables precise gene regulation that can be harnessed for synthetic biology and therapeutics.
• Its annotation in GO supports functional genomics and systems biology analyses.
What Happens During regulatory ncRNA-mediated gene silencing?
Transcription and Processing of Regulatory ncRNAs
In simple terms: First, the cell makes a non-coding RNA and trims it into its active form.
The process begins with transcription of a regulatory non-coding RNA gene by RNA polymerase II or III, producing a primary transcript that undergoes processing such as cleavage, capping, polyadenylation, or chemical modification. For example, long non-coding RNAs like Kcnq1ot1 are transcribed and processed in the nucleus. In yeast, XUTs are antisense transcripts that are sensitive to the exonuclease Xrn1, indicating processing and turnover. This step generates the mature inhibitory RNA molecule.
Nuclear Export and RISC Loading
In simple terms: The RNA then travels out of the nucleus and gets loaded into a protein complex called RISC.
After processing, many regulatory ncRNAs are exported from the nucleus to the cytoplasm via exportin proteins. Once in the cytoplasm, they are loaded onto Argonaute proteins to form the RNA-induced silencing complex (RISC). This loading involves unwinding of the RNA duplex and selection of the guide strand. For piRNAs, loading onto PIWI proteins occurs in the germline. The RISC complex is the central effector of post-transcriptional silencing.
Target Recognition and Transcriptional Silencing
In simple terms: The RNA finds its target gene and can shut it down by changing chromatin.
In the nucleus, regulatory ncRNAs can mediate transcriptional silencing by recruiting chromatin-modifying complexes to target loci. For instance, Kcnq1ot1 interacts with chromatin to establish heterochromatin and repress genes in cis. Polycomb group proteins are often involved in this process, leading to histone modifications such as H3K27me3 and subsequent transcriptional repression. This pre-transcriptional mechanism prevents RNA polymerase from accessing the gene.
Post-Transcriptional Silencing: RNA Degradation and Splicing Interference
In simple terms: In the cytoplasm, the RNA can destroy target messages or block their splicing.
Cytoplasmic RISC complexes can cleave target mRNAs through Argonaute slicer activity or recruit deadenylation and decapping factors, leading to exonucleolytic degradation. Additionally, regulatory ncRNAs can interfere with splicing by masking splice sites or modulating spliceosome assembly. These co- and post-transcriptional mechanisms reduce the amount of functional protein produced.
Translational Repression
In simple terms: The RNA can also stop the target message from being translated into protein.
RISC can repress translation initiation or elongation by competing with eIF4F complex binding, promoting ribosome drop-off, or inducing mRNA decay in P-bodies. This translational block is a major mode of microRNA action. The net effect is reduced protein synthesis without necessarily degrading the mRNA.
Key Genes Involved in GO:0031047 regulatory ncRNA-mediated gene silencing
The following genes and proteins are central to regulatory ncRNA-mediated gene silencing, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AGO1 | Core component of RISC; binds small RNAs and cleaves target mRNAs | Essential for post-transcriptional silencing; knockout models show loss of miRNA function |
| AGO2 | Slicer-competent Argonaute; mediates siRNA-directed cleavage | Key for RNAi; point mutations in catalytic domain abolish slicing |
| PIWIL1 | PIWI-family protein binding piRNAs; involved in germline silencing | Dysregulated in hepatocellular carcinoma; ceRNA networks |
| PIWIL2 | PIWI-family protein; essential for piRNA biogenesis and transposon silencing | Multi-omics studies reveal altered expression in cancer |
| Kcnq1ot1 | Long non-coding RNA that recruits chromatin modifiers for imprinting | Model for lncRNA-mediated transcriptional silencing |
| XRN1 | Exonuclease that degrades uncapped or antisense ncRNAs | Controls XUT levels in yeast; conserved RNA turnover |
| DICER1 | Ribonuclease that processes pre-miRNAs into mature miRNAs | Knockout leads to loss of miRNA-mediated silencing |
| DROSHA | Nuclear RNase III that cleaves primary miRNA transcripts | Required for miRNA biogenesis; mutations affect silencing |
| EZH2 | Histone methyltransferase of Polycomb complex; mediates H3K27me3 | Recruited by ncRNAs for transcriptional silencing |
| SUZ12 | Polycomb group protein; component of PRC2 | Interacts with ncRNAs to establish heterochromatin |
| GW182 (TNRC6) | Scaffold protein in RISC; recruits deadenylation factors | Knockdown impairs miRNA-mediated translational repression |
| MOV10 | RNA helicase associated with RISC; facilitates silencing | Modulates miRNA activity; potential antiviral factor |
| LIN28 | RNA-binding protein that blocks let-7 miRNA processing | Regulates stem cell differentiation and cancer |
| HOTAIR | Long non-coding RNA that recruits PRC2 to target genes | Promotes cancer metastasis; model for lncRNA silencing |
| MALAT1 | Long non-coding RNA involved in splicing regulation | Dysregulated in cancers; potential biomarker |
| NEAT1 | Long non-coding RNA component of paraspeckles | Implicated in gene regulation and cancer |
| XIST | Long non-coding RNA that mediates X-chromosome inactivation | Classic example of ncRNA-mediated transcriptional silencing |
| miR-200c | MicroRNA that targets ZEB1/2; regulates EMT | Involved in endometriosis via LINC01140 network |
How Is regulatory ncRNA-mediated gene silencing Regulated?
The process of regulatory ncRNA-mediated gene silencing is itself subject to multiple layers of regulation. The abundance and processing of ncRNAs are controlled by transcription factors, RNA-binding proteins, and nucleases such as Xrn1. For example, LIN28 can block the processing of let-7 miRNA, thereby modulating silencing. Additionally, the activity of RISC components can be regulated by post-translational modifications and interacting proteins like MOV10. In disease contexts, competing endogenous RNA (ceRNA) networks can sequester miRNAs and alter silencing efficiency, as seen in endometriosis and cancer. These regulatory mechanisms ensure dynamic control of gene expression.
regulatory ncRNA-mediated gene silencing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HOTAIR | Cancer metastasis | Knockout in cancer cell lines; overexpression in xenografts |
| PIWIL1 | Hepatocellular carcinoma | Knockout mouse models; multi-omics profiling |
| LINC01140 | Endometriosis | Knockdown in endometrial stromal cells; ceRNA network analysis |
| Kcnq1ot1 | Imprinting disorders (Beckwith-Wiedemann syndrome) | Knockout in mouse models; chromatin analysis |
| AGO2 | Cancer and RNAi defects | Point mutation of catalytic residues; knock-in of slicer-dead mutant |
Cancer
Dysregulation of ncRNA-mediated silencing is a hallmark of many cancers. Long non-coding RNAs such as HOTAIR and MALAT1 are overexpressed in various tumors and promote oncogenesis by recruiting chromatin modifiers or sponging miRNAs. PIWIL genes show altered expression in hepatocellular carcinoma, affecting ceRNA networks. Additionally, mutations in core silencing machinery like AGO2 can disrupt miRNA function, contributing to tumor progression.
Chronic Pain
Emerging evidence implicates ncRNAs in the development of chronic pain. MicroRNAs and long non-coding RNAs can modulate pain signaling pathways by silencing genes involved in neuronal excitability and inflammation. Targeting these ncRNAs may offer novel therapeutic avenues for pain management.
Endometriosis
In endometriosis, competing endogenous RNA networks involving LINC01140/miR-200c-3p and LINC01550/miR-363-3p play pivotal roles in disease progression. These lncRNAs act as miRNA sponges, altering the silencing of target genes and promoting cell proliferation and invasion.
Stem Cell Biology and Development
Polycomb group proteins and ncRNAs are critical for stem cell maintenance and differentiation. Disruption of ncRNA-mediated silencing can lead to developmental defects and contribute to cancer stem cell phenotypes.
From regulatory ncRNA-mediated gene silencing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a specific ncRNA silence a target gene? | Knockout of the ncRNA gene using CRISPR-Cas9 followed by RNA-seq |
| Is a catalytic residue of AGO2 required for silencing? | Point mutation (e.g., D669A) knock-in in cell lines |
| How does a disease-associated mutation affect silencing? | Knock-in of the patient mutation; functional assays |
| Where does a silencing complex localize? | Tagged knock-in of AGO2 with GFP; live-cell imaging |
| Can overexpression of a lncRNA drive oncogenesis? | Overexpression of HOTAIR in cancer cell lines; xenograft models |
| What is the role of PIWI proteins in cancer? | Knockout and overexpression of PIWIL genes in mouse models |
How to Study the regulatory ncRNA-mediated gene silencing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels | Identify genes derepressed upon ncRNA knockout |
| CLIP-seq | Protein-RNA interactions | Map Argonaute binding sites transcriptome-wide |
| ChIP-seq | Histone modifications and chromatin proteins | Study heterochromatin assembly by lncRNAs |
| Ribo-seq | Translational efficiency | Confirm miRNA-mediated translational repression |
| Proteomics | Protein abundance | Validate silencing effects at protein level |
| Luciferase reporter assay | Direct target repression | Test miRNA binding sites in 3' UTR |
| Northern blot | ncRNA processing and stability | Analyze XUT degradation in yeast |
| Fluorescence in situ hybridization (FISH) | ncRNA localization | Visualize nuclear vs cytoplasmic distribution |
RNA Sequencing (RNA-seq)
RNA-seq measures global changes in gene expression upon manipulation of ncRNA silencing components. It can identify direct and indirect targets of silencing and reveal ceRNA network rewiring. For example, RNA-seq after knockout of a lncRNA can show derepression of target genes.
Crosslinking and Immunoprecipitation (CLIP-seq)
CLIP-seq identifies RNA targets bound by Argonaute or other RISC proteins, providing a transcriptome-wide map of silencing interactions. This method reveals the exact binding sites and helps distinguish direct from indirect effects.
Chromatin Immunoprecipitation (ChIP-seq)
ChIP-seq detects histone modifications and chromatin-associated proteins at target loci, useful for studying transcriptional silencing mediated by ncRNAs like Kcnq1ot1. It can show changes in H3K27me3 or H3K9me3 upon ncRNA perturbation.
Proteomics and Ribosome Profiling
Mass spectrometry-based proteomics quantifies protein-level changes, while ribosome profiling (Ribo-seq) measures translation efficiency. These methods are essential to confirm translational repression by miRNAs and to identify downstream effects.
How CRISPR Can Be Used to Study GO:0031047 regulatory ncRNA-mediated gene silencing
Knockout
CRISPR-Cas9 knockout of ncRNA genes or silencing machinery components (e.g., AGO2, DICER1) is used to abolish silencing and observe downstream effects. For example, knockout of a lncRNA can lead to loss of heterochromatin and reactivation of target genes. This approach is ideal for loss-of-function studies.
Point Mutation
Point mutations can be introduced into catalytic residues of Argonaute proteins or into ncRNA binding sites to dissect mechanism. For instance, mutating the slicer activity of AGO2 allows separation of slicing-dependent and independent silencing. This provides precise mechanistic insights.
Knock-in
Knock-in of tagged versions of RISC components (e.g., GFP-AGO2) enables localization and interaction studies. Knock-in of disease-associated mutations in ncRNA genes or their targets can model human disorders. This approach preserves endogenous regulation.
Overexpression
Overexpression of a regulatory ncRNA (e.g., HOTAIR) or a silencing protein can drive gain-of-function phenotypes, such as oncogenic transformation. This is useful for studying the consequences of ncRNA dysregulation in cancer and other diseases.
How EDITGENE Supports regulatory ncRNA-mediated gene silencing Research
Researchers studying regulatory ncRNA-mediated gene silencing-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of ncRNA silencing components.
Contact EDITGENE today to design your custom CRISPR model for regulatory ncRNA-mediated gene silencing research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FMR1 Knockout HEK293T Cell Line | EDJ-KQ215 | Human | 2332 | Details Get a Quote |
| ZFP36 Knockout HEK293 Cell Line | EDJ-KQ1014 | Human | 7538 | Details Get a Quote |
| WTIP Knockout HEK293 Cell Line | EDJ-KQ1362 | Human | 126374 | Details Get a Quote |
| CNOT9 Knockout HEK293 Cell Line | EDJ-KQ2609 | Human | 9125 | Details Get a Quote |
| AGO3 Knockout HEK293 Cell Line | EDJ-KQ3081 | Human | 192669 | Details Get a Quote |
| FMR1 Knockout HEK293 Cell Line | EDJ-KQ3472 | Human | 2332 | Details Get a Quote |
| EIF4ENIF1 Knockout HEK293 Cell Line | EDJ-KQ3549 | Human | 56478 | Details Get a Quote |
| FKBP6 Knockout HEK293 Cell Line | EDJ-KQ6249 | Human | 8468 | Details Get a Quote |
| PIWIL1 Knockout HEK293 Cell Line | EDJ-KQ6533 | Human | 9271 | Details Get a Quote |
| DDX17 Knockout HEK293 Cell Line | EDJ-KQ7080 | Human | 10521 | Details Get a Quote |
| TNRC6B Knockout HEK293 Cell Line | EDJ-KQ7841 | Human | 23112 | Details Get a Quote |
| CNOT10 Knockout HEK293 Cell Line | EDJ-KQ8292 | Human | 25904 | Details Get a Quote |
| SND1 Knockout HEK293 Cell Line | EDJ-KQ8653 | Human | 27044 | Details Get a Quote |
| CNOT7 Knockout HEK293 Cell Line | EDJ-KQ9066 | Human | 29883 | Details Get a Quote |
| TRIM71 Knockout HEK293 Cell Line | EDJ-KQ9267 | Human | 131405 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About regulatory ncRNA-mediated gene silencing
What is GO:0031047?
GO:0031047 is the Gene Ontology term for regulatory ncRNA-mediated gene silencing, a process where non-coding RNAs reduce target gene expression at transcriptional or post-transcriptional levels.
What genes are involved in regulatory ncRNA-mediated gene silencing?
Key genes include AGO1, AGO2, PIWIL1, PIWIL2, DICER1, DROSHA, Kcnq1ot1, XRN1, EZH2, SUZ12, and various lncRNAs like HOTAIR and MALAT1.
How does ncRNA-mediated gene silencing work?
It starts with transcription of a regulatory ncRNA, followed by processing, nuclear export, RISC loading, and target recognition, leading to heterochromatin formation, RNA degradation, splicing interference, or translational repression.
What are the synonyms for GO:0031047?
Synonyms include gene silencing by RNA, RNA-dependent gene silencing, and RNA-mediated gene silencing.
Which diseases are linked to ncRNA-mediated silencing?
Cancers, chronic pain, endometriosis, and imprinting disorders such as Beckwith-Wiedemann syndrome are linked to dysregulated ncRNA silencing.
What is the role of Kcnq1ot1 in gene silencing?
Kcnq1ot1 is a long non-coding RNA that recruits chromatin modifiers to establish heterochromatin and repress target genes in cis.
How are PIWI proteins involved in silencing?
PIWI proteins bind piRNAs and mediate transposon silencing in the germline; their dysregulation is observed in hepatocellular carcinoma.
What methods are used to study ncRNA-mediated silencing?
Common methods include RNA-seq, CLIP-seq, ChIP-seq, Ribo-seq, proteomics, luciferase assays, and CRISPR-based perturbations.
Can CRISPR be used to study ncRNA silencing?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of ncRNA silencing components and their roles in disease.
What is the difference between transcriptional and post-transcriptional silencing?
Transcriptional silencing occurs via heterochromatin assembly and prevents transcription, while post-transcriptional silencing degrades mRNA or blocks translation.
Conclusion
GO:0031047, regulatory ncRNA-mediated gene silencing, is a central mechanism of gene regulation with broad implications for development, disease, and therapeutic innovation. Its complexity spans RNA processing, RISC assembly, chromatin modification, and translational control, involving a diverse array of genes and ncRNAs. Dysregulation of this process contributes to cancer, chronic pain, endometriosis, and other disorders. Advances in CRISPR-based models and high-throughput sequencing are accelerating our understanding of these pathways. EDITGENE provides the tools and expertise to functionally validate ncRNA silencing components, empowering researchers to translate discoveries into clinical applications.
References
- 1. Kanduri C. 2011. Kcnq1ot1: a chromatin regulatory RNA.. Semin Cell Dev Biol 22(4):343-50 PMID: 21345374
- 2. Antonazzo G et al.. 2024. Representation of non-coding RNA-mediated regulation of gene expression using the Gene Ontology.. RNA Biol 21(1):36-48 PMID: 39374113
- 3. García-Domínguez M. 2025. Role of ncRNAs in the Development of Chronic Pain.. Noncoding RNA 11(4) PMID: 40700093
- 4. Gieni RS et al.. 2009. Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.. Biochem Cell Biol 87(5):711-46 PMID: 19898523
- 5. Charidemou E et al.. 2026. Non-Coding RNAs in Cancer: Decoding Regulatory Networks for Liquid Biopsy Applications.. Genes (Basel) 17(4) PMID: 42074564
- 6. Huang H et al.. 2024. PIWIL genes in hepatocellular carcinoma: a multi-omics approach uncovering dysregulated expression and ceRNA networks in mice.. BMC Genom Data 25(1):101 PMID: 39604866
- 7. Huang Y et al.. 2025. LINC01140/miR-200c-3p and LINC01550/miR-363-3p networks play pivotal role in orchestrating progression of endometriosis†.. Biol Reprod 113(5):1237-1253 PMID: 40689544
- 8. van Dijk EL et al.. 2011. XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast.. Nature 475(7354):114-7 PMID: 21697827
